Oral azacitidine is a chemotherapy medicine used as continued treatment for certain adults with acute myeloid leukaemia who achieved remission after intensive chemotherapy. It helps maintain remission and delay recurrence when further intensive curative treatment cannot be completed.
| Generic Name | Azacitidine |
| Strength | 300 mg |
| Manufacturer | Hetero |
| Packing | 14 Tablets |
| Prescribed For | Blood cancer and treatment of myelodysplastic syndrome |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries. |




Azacitidine becomes incorporated into the RNA and DNA of abnormal blood cells. It changes gene activity and interferes with the production of new genetic material. These effects can restore more normal cell behaviour and reduce the growth of leukaemia cells.